Claire is a biologist by training, and earned her PhD in molecular and cellular biology at the Institute of Genetics, Molecular and Cellular Biology (IGBMC) in Strasbourg, France. Claire then joined the pharmaceutical industry to work on drug development in several capacities for about 13 years. She joined Wyeth Pharmaceutical (Paris office) as a Senior Clinical Scientist contributing to global phase 3 registration trials, NDA dossier submission and new product launch. Then with Pfizer Neuroscience she led teams in designing and conducting clinical plans from First in Human to Proof of Concept studies for small molecules, biologics and biomarker technologies. Over the years, Claire developed a passion for the business aspects of innovation. She became a standing member on the Portfolio Enhancement team responsible for screening external opportunities for business development and did an internship with Pfizer's Strategic Investment team in 2015.
Claire obtained her MBA from MIT Sloan in June 2016.